AN2 Therapeutics Inc.
06/09/2026 | Press release | Distributed by Public on 06/09/2026 04:01
Proxy Results (Form 8-K)
Item 5.07 Submission of Matters to a Vote of Security Holders.
On June 3, 2026, AN2 Therapeutics, Inc. (the "Company") held its 2026 annual meeting of stockholders (the "Annual Meeting"). Present at the beginning of the Annual Meeting in person or via proxy were the holders of 22,741,535 shares of common stock of the Company, representing 63.18% of the 35,995,545 shares of common stock outstanding as of the close of business on April 15, 2026, the record date for the Annual Meeting, and constituting a quorum for the transaction of business.
At the Annual Meeting, the Company's stockholders voted on two proposals, each of which is described in more detail in the Company's definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 22, 2026. The following is a brief description of each matter voted upon and the certified results, including the number of votes cast for or against each matter and, if applicable, the number of votes withheld, abstentions and broker non-votes with respect to each matter.
1.
To elect the nominees Kabeer Aziz, Gilbert Lynn Marks, M.D. and Rob Readnour, Ph.D. as Class I directors until the Company's 2029 annual meeting of stockholders or until their respective successors have been elected or appointed. The voting results were as follows:
|
Name |
Votes For |
Votes Withheld |
Broker |
|||
|
Kabeer Aziz |
13,547,536 |
3,958,874 |
5,235,125 |
|||
|
Gilbert Lynn Marks, M.D. |
15,947,854 |
1,558,556 |
5,235,125 |
|||
|
Rob Readnour, Ph.D. |
15,920,563 |
1,585,847 |
5,235,125 |
2.
To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. The voting results were as follows:
|
Votes For |
Votes Against |
Abstentions |
||
|
22,724,674 |
13 |
16,848 |
3.
AN2 Therapeutics Inc. published this content on June 09, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 09, 2026 at 10:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]